Subscribe to RSS
DOI: 10.1055/a-2568-9060
Association of Prepregnancy Obesity versus Excessive Gestational Weight Gain with Adverse Maternal Outcomes in the United States
Funding This work was supported by the U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute (grant number: HL141849).

Abstract
Objective
Prepregnancy body mass index (BMI) >30 kg/m2 or prepregnancy obesity (PPO) and excessive gestational weight gain (eGWG) are associated with increased risks for adverse maternal outcomes. There is little is known regarding the individual effects of PPO and eGWG. The objective of this study was to compare the effects of PPO and eGWG with adverse maternal outcomes.
Study Design
This was a retrospective cohort study of singleton, live births in the United States in 2018 using data from the National Vital Statistics System. Pregnancies complicated by pregestational diabetes, chronic hypertension, and with unknown maternal BMI were excluded. Institute of Medicine recommendations were used to define gestational weight gain (GWG). These births were divided into four groups: (1) normal prepregnancy BMI and normal GWG, (2) normal prepregnancy BMI and eGWG, (3) PPO and normal GWG, and (4) PPO and eGWG. Outcomes such as gestational diabetes, hypertensive disorders of pregnancy, cesarean delivery, maternal transfusion, and medical intensive care unit admissions were compared among groups using analysis of variance and multivariable logistic regression analysis.
Results
Of the 1,432,602 births included in the study, 22.2, 42.3, 10.1, and 25.4% were in Groups 1 to 4, respectively. Compared with pregnancies in Group 1 (adjusted odds ratio [95% confidence interval]), Groups 3 and 4 had higher risk for gestational diabetes (2.80 [2.72–2.88] and 2.28 [2.22–2.34]), respectively, whereas Groups 2 to 4 had higher risk of hypertensive disease of pregnancy (1.58 [1.53–1.64], 3.88 [3.74–4.03], and 5.07 [4.90–5.23]); eclampsia (1.61 [1.33–1.95], 2.99 [2.42–3.69], and 3.57 [2.97–4.29]), and cesarean delivery (1.21 [1.19–1.23], 1.97 [1.92–2.02], and 2.45 [2.40–2.50]), respectively.
Conclusion
Both PPO and eGWG are independently associated with higher odds of gestational diabetes, gestational hypertension, preeclampsia, and cesarean sections, with the highest risk among pregnancies with both PPO and eGWG. These data support the importance of prepregnancy weight management in preventing adverse pregnancy outcomes.
Key Points
-
Maternal obesity is associated with adverse maternal outcomes.
-
Maternal obesity is due to PPO or eGWG.
-
To study the contribution of adverse maternal outcomes by PPO as distinct from eGWG.
Keywords
maternal obesity - prepregnancy obesity - excessive gestational weight gain - maternal outcomesPublication History
Received: 08 October 2024
Accepted: 28 March 2025
Accepted Manuscript online:
28 March 2025
Article published online:
17 April 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 2019; 15 (05) 288-298
- 2 Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin North Am 2016; 45 (04) 571-579
- 3 Poston L, Caleyachetty R, Cnattingius S. et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol 2016; 4 (12) 1025-1036
- 4 Ferrante Jr AW. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007; 262 (04) 408-414
- 5 Monaco-Brown M, Lawrence DA. Obesity and maternal-placental-fetal immunology and health. Front Pediatr 2022; 10: 859885
- 6 Rastogi S, Rastogi D. The epidemiology and mechanisms of lifetime cardiopulmonary morbidities associated with pre-pregnancy obesity and excessive gestational weight gain. Front Cardiovasc Med 2022; 9: 844905
- 7 American College of Obstetricians and Gynecologists. Obesity in pregnancy: ACOG practice bulletin, number 230. Obstet Gynecol 2021; 137 (06) e128-e144
- 8 Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: The National Academies Press; 2009. , Table 7.3
- 9 Wu Y, Wan S, Gu S. et al. Gestational weight gain and adverse pregnancy outcomes: a prospective cohort study. BMJ Open 2020; 10 (09) e038187
- 10 Kominiarek MA, Saade G, Mele L. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Association between gestational weight gain and perinatal outcomes. Obstet Gynecol 2018; 132 (04) 875-881
- 11 Dude AM, Grobman W, Haas D. et al. Gestational weight gain and pregnancy outcomes among nulliparous women. Am J Perinatol 2021; 38 (02) 182-190
- 12 Goldstein RF, Abell SK, Ranasinha S. et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA 2017; 317 (21) 2207-2225
- 13 ACOG Practice Bulletin No. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
- 14 Kolb H, Kempf K, Röhling M, Martin S. Insulin: too much of a good thing is bad. BMC Med 2020; 18 (01) 224
- 15 Hedderson MM, Williams MA, Holt VL, Weiss NS, Ferrara A. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol 2008; 198 (04) 409.e1-409.e7
- 16 Azher S, Pinheiro JMB, Philbin B, Gifford J, Khalak R. The impact of maternal obesity on NICU and newborn nursery costs. Front Pediatr 2022; 10: 863165
- 17 Sawangkum P, Louis JM. Gestational weight gain: achieving a healthier weight between pregnancies. Obstet Gynecol Clin North Am 2020; 47 (03) 397-407
- 18 O'Dwyer V, O'Toole F, Darcy S, Farah N, Kennelly MM, Turner MJ. Maternal obesity and gestational weight gain. J Obstet Gynaecol 2013; 33 (07) 671-674